Valuation (81%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.86 | N/A |
| PEG Ratio (TTM) | 0.16 | N/A |
| P/S Ratio (TTM) | 43.14 | N/A |
| P/B Ratio (TTM) | 1.03 | N/A |
| P/FCF Ratio (TTM) | 3.94 | N/A |
| Price to 5YR AVG Earnings Ratio | 31.48 | N/A |
| Price to 5YR AVG FCF Ratio | 13.80 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.48% | N/A |
| ROE (TTM) | 6.16% | N/A |
| Net Profit Margin (TTM) | 302.13% | N/A |
| ROIC 5YR AVG | 2.07% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 307.97% | 123.45% | -21.04% |
| Revenue | 53.38% | 67.64% | 36.30% |
| Net Income | 302.46% | 142.44% | -11.76% |
| Cash Flow | 572.29% | -35.98% | 216.22% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.56 | N/A |
| Quick Ratio (TTM) | 1.56 | N/A |
| D/E Ratio (TTM) | 0.43 | N/A |
| Interest Coverage (TTM) | 2.93 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 1.19 | N/A |
| LTL to 5YR AVG FCF | 7.15 | N/A |
| Shares Outstanding Growth 5YR AVG | 27.84% | N/A |